Abstract 695: Relative importance between DNA methylation and mutation in nonmalignant tissue for cancer risk

Abstract Cancer risk is correlated with the accumulation level of genetic (mutation) and epigenetic alterations (DNA methylation). Analysis of these alterations in nonmalignant tissue contributes to assessing cancer risk and to revealing environmental factors that induce the alterations. DNA methylation can be readily measured due to its high accumulation levels, while on the other hand, it is difficult to measure accumulation levels of mutations because of their rarity. To detect rare point mutations accurately and inexpensively, we developed a novel next generation sequencing (NGS) method, EcoSeq [Ueda, PNAS, 119:e2123241119, 2022]. Here, using EcoSeq, we aimed to evaluate the impact of DNA methylation and mutation for gastric cancer risk, and the mutational signatures of H. pylori (HP) infection, which is a mutagen for gastric cancer. Nonmalignant gastric mucosae were obtained from G1 (low risk; never infected with HP), G2 (intermediate; healthy people after HP eradication) and G3 (high; cancer patients after HP eradication). The mutation frequency was slightly increased by history of HP infection (p=<0.0001, G1vsG2), but not associated with cancer risk (p=0.50, G2vsG3). On the other hand, the DNA methylation level of miR124a-3 was strongly correlated with cancer risk (p<0.0001, G1vsG2; 0.00069, G2vsG3). Mutational signatures of SBS39 were observed in G2 and G3. These results showed that DNA methylation was more useful for assessing gastric cancer risk than point mutation frequency, and suggested that SBS39 is due to HP infection. Citation Format: Harumi Yamada, Satoshi Yamashita, Yu-Yu Liu, Toshikazu Ushijima. Relative importance between DNA methylation and mutation in nonmalignant tissue for cancer risk [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 695.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2025-04-21
DOI
https://doi.org/10.1158/1538-7445.am2025-695
Primary Topic
Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 695: Relative importance between DNA methylation and mutation in nonmalignant tissue for cancer risk

Harumi Yamada, Satoshi Yamashita, Toshikazu Ushijima, Yuyu Liu
Cancer Research
Cancer Diagnosis and Treatment
article

Abstract 695: Relative importance between DNA methylation and mutation in nonmalignant tissue for cancer risk

Harumi Yamada, Satoshi Yamashita, Toshikazu Ushijima, Yuyu Liu
article en

Abstract

Abstract Cancer risk is correlated with the accumulation level of genetic (mutation) and epigenetic alterations (DNA methylation). Analysis of these alterations in nonmalignant tissue contributes to assessing cancer risk and to revealing environmental factors that induce the alterations. DNA methylation can be readily measured due to its high accumulation levels, while on the other hand, it is difficult to measure accumulation levels of mutations because of their rarity. To detect rare point mutations accurately and inexpensively, we developed a novel next generation sequencing (NGS) method, EcoSeq [Ueda, PNAS, 119:e2123241119, 2022]. Here, using EcoSeq, we aimed to evaluate the impact of DNA methylation and mutation for gastric cancer risk, and the mutational signatures of H. pylori (HP) infection, which is a mutagen for gastric cancer. Nonmalignant gastric mucosae were obtained from G1 (low risk; never infected with HP), G2 (intermediate; healthy people after HP eradication) and G3 (high; cancer patients after HP eradication). The mutation frequency was slightly increased by history of HP infection (p=<0.0001, G1vsG2), but not associated with cancer risk (p=0.50, G2vsG3). On the other hand, the DNA methylation level of miR124a-3 was strongly correlated with cancer risk (p<0.0001, G1vsG2; 0.00069, G2vsG3). Mutational signatures of SBS39 were observed in G2 and G3. These results showed that DNA methylation was more useful for assessing gastric cancer risk than point mutation frequency, and suggested that SBS39 is due to HP infection. Citation Format: Harumi Yamada, Satoshi Yamashita, Yu-Yu Liu, Toshikazu Ushijima. Relative importance between DNA methylation and mutation in nonmalignant tissue for cancer risk [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 695.

Cancer ResearchVol. 85(8_Supplement_1)
Hoshi University (JP)
Openalex Percentile: Top 88%
Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.